Malignant Germ Cell Tumor  >>  oxaliplatin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT00393861: Study of Oxaliplatin Plus Bevacizumab in Germ Cell Tumor Patients

Completed
2
29
US
Bevacizumab and Oxaliplatin
Indiana University, Genentech, Inc.
Neoplasms, Germ Cell and Embryonal
10/12
11/14

Download Options